A multi-national, multi-centre, prospective, single-arm, observational, non-interventional post-authorisation safety study to investigate long-term safety of Sogroya? (somapacitan) in adults with growth hormone deficiency (AGHD) under normal routine practice (REAL 7)

Is this Study for You?

Let's Get Started!

Description

We are doing this study to collect information about how safe and effective Sogroya ? (somapacitan) is, when used for treatment of people with Adult Growth Hormone Deficiency (AGHD) such as yourself. Sogroya ? (somapacitan), which is prescribed to you by your doctor. It is commercially available in your country as well as in many other countries and has been approved by regulatory authorities.

Details
Age

Adult

Eligibility

Diagnosis of Adult Growth Hormone Deficiency (AGHD). Currently being treated or planned to start treatment with Sogroya? (somapacitan).

Locations

University of Colorado Hospital

Principal Investigator
Photograph of Christie Turin more

Christie Turin more

Study ID

Protocol Number: 23-1727

More information available at ClinicalTrials.gov: NCT05718570

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers